As our above data indicated that high expression of AIB1 is associated with the poor response to definitive chemoradiotherapy, thus, we performed standard clonogenic formation assay to further determine the anti-radiotherapy effect of AIB1 in cervical cancer cells. This evidence concerns the gene NCOA3 and cervical carcinoma.